Fishman, M. 2010. Treatment planning, matching and placement for adolescent substance abuse. In Clinical manual of adolescent substance abuse treatment, edited by Y. Kaminer and K. Winters. Arlington, VA: American Psychiatric Publishing. Pp. 113-135.
Garfield, R. L., S. H. Zuvekas, J. R. Lave, and J. M. Donohue. 2011. The impact of national health care reform on adults with severe mental disorders. American Journal of Psychiatry 168(5):486-494.
Goldman, H. H., R. G. Frank, M. A. Burnam, H. A. Huskamp, M. S. Ridgely, S. L. T. Normand, A. S. Young, C. L. Barry, V. Azzone, A. B. Busch, S. T. Azrin, G. Moran, C. Lichtenstein, and M. Blasinsky. 2006. Behavioral health insurance parity for federal employees. New England Journal of Medicine 354(13):1378-1386.
Gourevitch, M. N., and J. H. Arnsten. 2005. Medical complications of drug use. In Substance abuse: A comprehensive textbook, edited by J. H. Lowinson. Philadelphia, PA: Lippincott Williams & Wilkins.
Gustafson, D. H., and K. Johnson. 2012. The NIATx model: Process improvement for behavioral health. Madison, WI: Wisconsin-Madison’s Center for Health Enhancement Systems Studies.
Hoffman, K. A., J. H. Ford, 2nd, D. Choi, D. H. Gustafson, and D. McCarty. 2008. Replication and sustainability of improved access and retention within the network for the improvement of addiction treatment. Drug and Alcohol Dependence 98(1-2):63-69.
Hoffman, N. G., J. A. Halikas, D. Mee-Lee, and R. D. Weedman. 1991. Patient placement criteria for the treatment of psychoactive substance use disorders. Washington, DC: ASAM.
Humphreys, K., and A. T. McLellan. 2011. A policy-oriented review of strategies for improving the outcomes of services for substance use disorder patients. Addiction 106:2058-2066.
IOM (Institute of Medicine). 2000. To err is human: Building a safer health system. Washington, DC: National Academy Press.
IOM. 2001. Crossing the quality chasm: A new health system for the 21st century. Washington, DC: National Academy Press.
IOM. 2006. Improving the quality of health care for mental and substance-use conditions: Quality chasm series. Washington, DC: The National Academies Press.
Korthuis, P. T., J. Gregg, W. E. Rogers, D. McCarty, C. Nicolaidis, and J. Boverman. 2010. Patients’ reasons for choosing office-based buprenorphine: Preference for patient-centered care. Journal of Addiction Medicine 4(4):204-210.
Korthuis, P. T., D. A. Fiellin, R. Fu, P. J. Lum, F. L. Altice, N. Sohler, M. J. Tozzi, S. M. Asch, M. Botsko, M. Fishl, T. P. Flanigan, J. Boverman, and D. McCarty. 2011a. Improving adherence to HIV quality of care indicators in persons with opioid dependence: The role of buprenorphine. Journal of Acquired Immune Deficiency Syndromes 56(Suppl. 1):S83-S90.
Korthuis, P. T., M. J. Tozzi, V. Nandi, D. A. Fiellin, L. Weiss, J. E. Egan, M. Botsko, A. Acosta, M. N. Gourevitch, D. Hersh, J. Hsu, J. Boverman, and F. L. Altice. 2011b. Improved quality of life for opioid-dependent patients receiving buprenorphine treatment in HIV clinics. Journal of Acquired Immune Deficiency Syndromes 56(Suppl. 1):S39-S45.
Manwell, L. B., M. F. Fleming, K. Johnson, and K. L. Barry. 1998. Tobacco, alcohol, and drug use in a primary care sample: 90-day prevalence and associated factors. Journal of Addictive Disorders 17(1):67-81.
McCarty, D., B. E. Fuller, C. Arfken, M. Miller, E. V. Nunes, E. Edmundson, M. Copersino, A. Floyd, R. Forman, R. Laws, K. M. Magruder, M. Oyama, K. Prather, J. Sindelar, and W. W. Wendt. 2007a. Direct care workers in the national drug abuse treatment clinical trials network: Characteristics, opinions, and beliefs. Psychiatric Services 58(2):181-190.
McCarty, D., D. H. Gustafson, J. P. Wisdom, J. Ford, D. Choi, T. Molfenter, V. Capoccia, and F. Cotter. 2007b. The Network for the Improvement of Addiction Treatment (NIATx): Enhancing access and retention. Drug and Alcohol Dependence 88(2-3):138-145.